Privia Health Group, Inc. (PRVA)

Privia Health Group Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, Privia Health Group stock has a consensus rating of "Strong Buy" and an average price target of $31.58. The average 1-year stock price forecast is 35.57% higher than the current stock price, while the lowest is $25 (+7.32%) and the highest is $40 (+71.71%).

Price Target: $31.58 (+35.57%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$25	$31.58	$31	$40
Change	+7.32%	+35.57%	+33.08%	+71.71%

Analyst Ratings

The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	3
Buy	9	9	9	9	9	8
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	14	14	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $35 → $34	Strong Buy	Maintains	$35 → $34	+45.95%	May 8, 2026
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Buy Maintains $30 → $26	Buy	Maintains	$30 → $26	+11.61%	Apr 8, 2026
Andrew Mok Barclays	Barclays	Hold Maintains $23 → $25	Hold	Maintains	$23 → $25	+7.32%	Mar 25, 2026
Daniel Grosslight Citigroup	Citigroup	Strong Buy Maintains $34 → $32	Strong Buy	Maintains	$34 → $32	+37.37%	Mar 3, 2026
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $31 → $33	Strong Buy	Maintains	$31 → $33	+41.66%	Mar 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.52B

Increased by 18.66%

from 2.12B

Revenue Next Year

2.78B

Increased by 10.48%

from 2.52B

EPS This Year

0.36

Increased by 97.81%

from 0.18

EPS Next Year

0.46

Increased by 28.46%

from 0.36

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	966.22M	1.36B	1.66B	1.74B	2.12B	2.52B	2.78B
Revenue Growth	18.25%	40.41%	22.19%	4.75%	22.26%	18.66%	10.48%
EPS	-1.83	-0.08	0.19	0.11	0.18	0.36	0.46
EPS Growth	-	-	-	-42.11%	63.64%	97.81%	28.46%
Forward PE	-	-	-	-	-	65.42	50.93
No. Analysts	-	-	-	-	-	23	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031
High	3.9B	4.3B
Avg	2.5B	2.8B
Low	2.2B	2.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031
High	84.0%	71.0%
Avg	18.7%	10.5%
Low	5.1%	-3.1%

EPS Forecast

EPS	2026	2027	2028
High	0.50	0.68
Avg	0.36	0.46
Low	0.25	0.29

EPS Growth

EPS Growth	2026	2027	2028
High	180.0%	91.7%
Avg	97.8%	28.5%
Low	36.1%	-17.4%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.